Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Drug-Related Side Effects and Adverse Reactions
×
Cyclophosphamide
×
Clear all
Filters
3
NCT06302062
2024-12-03
TAL-T
Guangzhou FineImmune Biotechnology Co., LTD.
Phase 1
Recruiting
23 enrolled